drugset / Trial / NCT00597896

Cognitive Enhancement in Bipolar Disorder

NCT00597896

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine whether the medication pramipexole (Mirapex) may be able to improve cognitive problems (i.e. difficulties with thinking, memory, and concentration) that may be associated with bipolar disorder.

Timeline

Start
2005-10
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramipexole Unknown 0.75 mg Oral

Indications